NCT02678195View on ClinicalTrials.gov

3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi

PHASE4CompletedINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

December 31, 2019

Conditions
Pneumonia
Interventions
DRUG

Amoxicillin

Oral amoxicillin dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily

DRUG

Placebo

Placebo dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily

Trial Locations (2)

Unknown

Bwaila District Hospital, Lilongwe

Kamuzu Central Hospital, Lilongwe

All Listed Sponsors
collaborator

University of North Carolina

OTHER

collaborator

University of Washington

OTHER

lead

Save the Children

OTHER

NCT02678195 - 3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi | Biotech Hunter | Biotech Hunter